Avascular Necrosis Market - Summary

The global avascular necrosis (AVN) market, is set to reach an approximate evaluation of USD 1.12 Bn by the end of 2024 and experience a modest CAGR of 6.58% during the forecast period of 2018 to 2024. This projects a cautious upward trend which is driven by the considerable growth of the pharmaceutical sector in rapidly emerging economies.

Known by other names such as osteonecrosis or bone infarction, the condition is gaining global awareness thus supporting the growth of the AVN market. The disease which more commonly afflicts men between the ages of 30 to 50 years, has been highly prevalent in emerging economies.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/6131

Additionally, the rising cases of long-term steroid and alcohol abuse have further contributed to the prevalence of the disease. The eventual requirement of surgery and the widespread use of medication to control the symptoms of AVN is another factor driving sales of drugs such as non-steroidal anti-inflammatory drugs. This factor is also responsible for the increased demand for alternative treatment options such as minimally invasive surgery. Moreover, osteonecrosis is challenging to diagnose, and there is no known cure, which has increased R&D focus on treatment alternatives outside of surgery.

Report Overview:

This MRFR report delivers a detailed perspective on the global market for avascular necrosis. In-depth information on the market pertaining to historical market trends and current market scenario along with market forecast for the next six years is offered in the report. Key macro and micro-economic factors affecting the global avascular necrosis market were also discussed.

The report includes analysis of types of avascular necrosis, disease site, diagnosis, treatment, and end-user. Based on types, into trauma-related avascular necrosis (AVN) and non-trauma related avascular necrosis (AVN) were considered for market sizing. Hip bone, knee, and shoulder were the prominent disease sites discussed in the report for market valuation. The market share captured by imaging diagnosis and biopsy diagnosis was also examined. Based on treatment, medication, electrical stimulation, gene therapy, and surgery made up for the overall market size. Based on end user, the key market segments covered in the report include hospitals & clinics, diagnostic centers, and ambulatory surgical centers. All the segments and sub-segments are profiled under five major regions–North America, Latin America, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA), with the respective country-level market sizes. The report analyses the current and future prospect of the market and delivers an unbiased growth assessment.

Competitive Dashboard:

Stryker Corporation, Medtronic plc, Ethicon Inc., Sanofi SA, Bayer AG, Pfizer Inc., Merck KGaA, Boehringer Ingelheim GmbH, Eli Lilly and Company, Aurobindo Pharma, Integra LifeSciences Corporation, Zimmer Biomet Holdings, Wright Medical Group N.V., Grifols SA, and Smith and Nephew.

Ask Any Question at https://www.marketresearchfuture.com/enquiry/6131

Avascular Necrosis Market - Regional Analysis:

The Americas lead the global market for avascular necrosis due to the presence of various reputable market leaders and the technological advancements in diagnostics in the region. Countries such as U.S. and Canada are leading growth for the Americas. The second largest regional market segment belongs to Europe, due to the presence of a well-developed healthcare sector with favorable policies regarding research and development.

The Asia-Pacific is expected to be the fastest growing market for AVN due to the presence of a vast population with an increased rate of occurrence for osteonecrosis. Moreover, manufacturing of medical devices has shifted prominently to this region due to the ease in availability of cheap labor costs and lower investments in necessary infrastructure.

Avascular Necrosis Market - Segmental Analysis:

The segments on the basis of type, site, diagnosis, treatment, end-user, and region are used for the segmentation of the avascular necrosis market globally. By type, the market has been segmented non-trauma related avascular necrosis (AVN) and into trauma-related avascular necrosis (AVN).

The non-trauma related avascular necrosis segment presently is credited for the major market share and is expected to continue to be extremely productive throughout the assessment period. By site, the segmentation of the market includes knee, hip bone, shoulder, and other. In the year 2017, the hip bone segment was worth USD 508 Mn approximately.

By diagnosis, the market has been segmented into biopsy and imaging. The imaging segment at present is attributable for the biggest market share in the year 2017. The treatment segment of the market has comprises of electrical stimulation, medication, gene therapy, and surgery. Among these segments, the oncology segment is anticipated to develop with the peaking CAGR percent during the forecast period. The end user segment the market has been segmented into diagnostic centers, hospitals & clinics, and ambulatory surgical centers. The hospitals & clinics will probably retain its top position by the end of 2024.

Major TOC of Avascular Necrosis Market Research Report – Forecast to 2024:

1  Executive Summary

2  Market Introduction

3  Research Methodology

4  Market Dynamics

5  Market Factor Analysis

6  Global Avascular Necrosis Market, by Type

7  Global Avascular Necrosis Market, by Site

8  Global Avascular Necrosis Market, by Diagnosis

9  Global Avascular Necrosis Market, by Treatment

10  Global Avascular Necrosis Market, by End-User

11  Global Avascular Necrosis Market, by Region

12  Competitive Landscape

13  Company Profiles

14  Conclusion

15  Appendix

Check Discount at https://www.marketresearchfuture.com/check-discount/6131

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]